Gerretsen et al. 74M Moderate Claudication

Gerretsen et al. 74M Moderate Claudication

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL—High Diagnostic Performance for Stenosis Detection1 Gerretsen et al.74-year-old man with moderate claudication in the calf (Fontaine IIb) These are representative images from reference studies; individual...
Seidl et al. 70M Metastatic Lung Carcinoma

Seidl et al. 70M Metastatic Lung Carcinoma

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.70-year-old man with metastatic lung carcinoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...
Seidl et al. 58F Metastatic Melanoma

Seidl et al. 58F Metastatic Melanoma

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT Study Seidl et al. 58-year-old woman with metastatic melanoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...
Rowley et al. 55F Glioblastoma with Recurrent Disease

Rowley et al. 55F Glioblastoma with Recurrent Disease

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Omniscan™ (gadodiamide)1 The ENHANCE Study Rowley et al.55-year-old woman with glioblastoma with recurrent disease These are representative images from...
Maravilla et al. 51F Metastatic Lung Cancer

Maravilla et al. 51F Metastatic Lung Cancer

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Magnevist® (gadopentetate dimeglumine)1 Maravilla et al.51-year-old woman with metastatic lung cancer These are representative images from reference...